CinCor Pharma, Inc.
CINCDelisted Feb 24, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001868734
CinCor Pharma, Inc. was delisted on Feb 24, 2023; its insiders filed their last Form 4 on Feb 28, 2023; 102 institutions reported holding it in 13F filings for Q4 2022, worth $460.7M in total; no superinvestor held it.
Q3 2022 vs. Q2 2022
How the institutions holding CinCor Pharma, Inc. changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Q3 2022 | Change |
|---|---|---|---|
| Holders | 57 | 86 | +29 |
| Shares | 31.6M | 37.3M | +5.66M (+17.9%) |
| Value | $595.6M | $1.22B | +$627.5M (+105.4%) |
New holders (34)
Institutions that held CinCor Pharma, Inc. at the end of Q3 2022 but not at the end of Q2 2022.
Sold out (5)
Institutions that held CinCor Pharma, Inc. at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Sands Capital Ventures, LLC | 950,000 | $17.9M |
| Artal Group S.A. | 137,010 | $2.58M |
| LMR Partners LLP | 22,914 | $432.0K |
| Captrust Financial Advisors | 109 | $2.00K |
| Glassman Wealth Services | 45 | $1.00K |